2025-04-01 2026-03-31 false Capium Accounts Production 1.1 16337717 2025-04-01 2026-03-31 16337717 bus:AbridgedAccounts 2025-04-01 2026-03-31 16337717 bus:FRS102 2025-04-01 2026-03-31 16337717 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 16337717 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 16337717 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 16337717 2025-04-01 2026-03-31 16337717 2026-03-31 16337717 bus:RegisteredOffice 2025-04-01 2026-03-31 16337717 core:WithinOneYear 2026-03-31 16337717 core:AfterOneYear 2026-03-31 16337717 1 2025-04-01 2026-03-31 16337717 bus:Director1 2025-04-01 2026-03-31 16337717 bus:Director1 2026-03-31 16337717 2024-04-01 16337717 bus:LeadAgentIfApplicable 2025-04-01 2026-03-31 16337717 2025-03-31 16337717 bus:OrdinaryShareClass1 2025-04-01 2026-03-31 16337717 bus:OrdinaryShareClass1 2026-03-31 16337717 core:CostValuation core:Non-currentFinancialInstruments 2026-03-31 16337717 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 16337717 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-03-31 16337717 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-03-31 16337717 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-03-31 16337717 core:Non-currentFinancialInstruments 2026-03-31 16337717 core:Non-currentFinancialInstruments 2025-03-31 16337717 core:ShareCapital 2026-03-31 16337717 core:RetainedEarningsAccumulatedLosses 2026-03-31 16337717 dpl:Item1 2025-04-01 16337717 dpl:Item1 2026-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 16337717


 

 

 

MUSSA MEDICAL LIMITED



Abridged Accounts
 


Period of accounts

Start date: 01 April 2025

End date: 31 March 2026
Accountant’s report
You consider that the company is exempt from an audit for the year ended 31 March 2026 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
AH & CO ACCOUNTANT LIMITED
31 March 2026



....................................................

AH & CO ACCOUNTANT LIMITED

Atrium House
574 Manchester Road
Bury
BL9 9SW
25 June 2026
1
 
 
Notes
 
2026
£
Current assets    
Debtors 5,818 
Cash at bank and in hand 2,802 
8,620 
Creditors: amount falling due within one year (3,938)
Net current assets 4,682 
 
Total assets less current liabilities 4,682 
Net assets 4,682 
 

Capital and reserves
   
Called up share capital 3 1 
Profit and loss account 4,681 
Shareholders' funds 4,682 
 


For the year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 25 June 2026 and were signed by:


-------------------------------
Naeem Mussa
Director
2
General Information
MUSSA MEDICAL LIMITED is a private company, limited by shares, registered in , registration number 16337717, registration address 31 EASTGATE, FULWOOD PRESTON, PR2 3HS.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
2.

Average number of employees

Average number of employees during the year was 1.
3.

Share Capital

Allotted, called up and fully paid
2026
£
1 Class A share of £1.00 each

3